CASI CASI Pharmaceuticals
- 5.5800
- +0.1500+2.76%
- 5.5800
- 0.00000.00%
CASI Pharmaceuticals News
CASI Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
CASI Pharmaceuticals | F-3/A: Registration statement for specified transactions by certain foreign private issuers (Amendment)
CASI Pharmaceuticals | F-3: Registration statement for specified transactions by certain foreign private issuers
CASI Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
CASI Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
CASI Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
CASI Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
CASI Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
CASI Pharmaceuticals | F-3: Registration statement for specified transactions by certain foreign private issuers
CASI Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
CASI Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
CASI Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
CASI Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
CASI Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
CASI Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
CASI Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
CASI Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
CASI Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
CASI Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
CASI Pharmaceuticals | S-8 POS: S-8 POS
Analysis
Price Target
No Data
No Data